Nevertheless, in the context of diagnosis and potential early detection of HCC, detecting the changes to VIM and FBLN1 methylation patterns in plasma cfDNA holds a promise for improved diagnosis and disease progression monitoring. This evidence concerns the gene FBLN1 and hepatocellular carcinoma.